ZTS

Zoetis

Health Care

Pharmaceuticals

Parsippany, New Jersey

Balance Sheet 36 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$2.0B	$2.0B	$3.6B	$3.5B	$3.6B
Assets - AccountsReceivable	$1.3B	$1.3B	$1.2B	$1.1B	$1.0B
Assets - Inventories	$2.3B	$2.6B	$2.3B	$1.9B	$1.6B
Assets - PrepaidExpensesAndOtherCurrentAssets	$377.0M	$434.0M	$365.0M	$389.0M	$366.0M
Assets - TotalCurrentAssets	$6.0B	$6.3B	$7.5B	$6.9B	$6.6B
Assets - Property,PlantAndEquipment	$3.4B	$3.2B	$2.8B	$2.4B	$2.2B
Assets - Goodwill	$2.7B	$2.8B	$2.7B	$2.7B	$2.7B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$1.1B	$1.3B	$1.4B	$1.5B	$1.7B
Assets - OperatingLeaseAssets	$219.0M	$230.0M	$220.0M	$181.0M	$192.0M
Assets - DeferredTaxAssets	$540.0M	$206.0M	$173.0M	$100.0M	$94.0M
Assets - OtherNoncurrentAssets	$250.0M	$206.0M	$147.0M	$111.0M	$106.0M
Assets - TotalAssets	$14.2B	$14.3B	$14.9B	$13.9B	$13.6B
Liabilities - AccountsPayable	$433.0M	$411.0M	$405.0M	$436.0M	$457.0M
Liabilities - AccruedLiabilities	$665.0M	$683.0M	$682.0M	$710.0M	$556.0M
Liabilities - ContractLiabilitiesCurrent(deferredRevenue)	$18.0M	$11.0M	$14.0M	$12.0M	$13.0M
Liabilities - ShortTermDebtAndCurrentPortionOfLongTermDebt	$1.4B	$0	$1.4B	$0	$600.0M
Liabilities - OperatingLeaseLiabilitiesCurrent	$51.0M	$48.0M	$43.0M	$41.0M	$40.0M
Liabilities - OtherCurrentLiabilities	$125.0M	$102.0M	$97.0M	$67.0M	$93.0M
Liabilities - TotalCurrentLiabilities	$3.4B	$1.9B	$3.2B	$1.8B	$2.2B
Liabilities - LongTermDebt	$5.2B	$6.6B	$6.6B	$6.6B	$6.6B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$174.0M	$188.0M	$186.0M	$151.0M	$163.0M
Liabilities - DeferredTaxLiabilitiesNoncurrent	$167.0M	$146.0M	$142.0M	$320.0M	$378.0M
Liabilities - OtherNoncurrentLiabilities	$222.0M	$237.0M	$217.0M	$239.0M	$270.0M
Liabilities - TotalLiabilities	$9.5B	$9.3B	$10.5B	$9.4B	$9.8B
Equity - PreferredStock	$1.0B	$1.0B	$1.0B	$1.0B	$1.0B
Equity - CommonStock	$5.0M	$5.0M	$5.0M	$5.0M	$5.0M
Equity - AdditionalPaidInCapital	$1.2B	$1.1B	$1.1B	$1.1B	$1.1B
Equity - RetainedEarnings(deficit)	$12.0B	$10.3B	$8.7B	$7.2B	$5.7B
Equity - TreasuryStock	$7.4B	$5.6B	$4.5B	$3.0B	$2.2B
Equity - AccumulatedOtherComprehensiveIncome(loss)	$-940.0M	$-839.0M	$-817.0M	$-764.0M	$-730.0M
Equity - NoncontrollingInterest(permanentEquity)	$0	$-6.0M	$-2.0M	$1.0M	$4.0M
Equity - TotalStockholdersEquity	$4.8B	$5.0B	$4.4B	$4.5B	$3.8B
Equity - TotalLiabilitiesAndStockholdersEquity	$14.2B	$14.3B	$14.9B	$13.9B	$13.6B
Equity - TotalLiabilitiesandEquity	$14.2B	$14.3B	$14.9B	$13.9B	$13.6B
Validation - L+E Components Sum Difference	$0	$0	$0	$0	$0

Income Statement 22 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetProductSales/Revenues	$9.3B	$8.5B	$8.1B	$7.8B	$6.7B
IncomeStatement - CostsAndExpenses - CostOfGoodsSold	$2.7B	$2.6B	$2.5B	$2.3B	$2.1B
IncomeStatement - CostsAndExpenses - ResearchAndDevelopmentExpense	$686.0M	$614.0M	$539.0M	$508.0M	$463.0M
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative(andMarketing)	$2.3B	$2.2B	$2.0B	$2.0B	$1.7B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$170.0M	$185.0M	$193.0M	$204.0M	$230.0M
IncomeStatement - CostsAndExpenses - Depreciation(operating)	$327.0M	$306.0M	$272.0M	$244.0M	$211.0M
IncomeStatement - CostsAndExpenses - RestructuringAndImpairmentCharges	$43.0M	$46.0M	$6.0M	$33.0M	$8.0M
IncomeStatement - OtherIncomeExpense - InterestExpense	$225.0M	$239.0M	$221.0M	$224.0M	$231.0M
IncomeStatement - OtherIncomeExpense - Gain(loss)OnDivestitures/saleOfAssets	$-23.0M	$101.0M	$0	$0	$19.0M
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$-4.0M	$-1.0M	$14.0M	$-4.0M	$-5.0M
IncomeStatement - OtherIncomeExpense - Income(loss)FromContinuingOperationsBeforeIncomeTaxes	$3.1B	$2.9B	$2.7B	$2.5B	$2.0B
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$637.0M	$596.0M	$545.0M	$454.0M	$360.0M
IncomeStatement - IncomeTax - EffectiveTaxRate(continuingOperations)	$0	$0	$0	$0	$0
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$2.5B	$2.3B	$2.1B	$2.0B	$1.6B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToNoncontrollingInterest	$10.0M	$-4.0M	$-3.0M	$-3.0M	$-2.0M
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$2.5B	$2.3B	$2.1B	$2.0B	$1.6B
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$5	$5	$5	$4	$3
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$5	$5	$4	$4	$3
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$454.2M	$461.2M	$468.9M	$474.3M	$475.5M
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$454.8M	$462.3M	$470.4M	$476.7M	$478.6M
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$2.4B	$2.3B	$2.1B	$2.0B	$1.6B

Cash Flow Statement 21 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - NetIncome	$2.5B	$2.3B	$2.1B	$2.0B	$1.6B
CashFlow - OperatingActivities - DepreciationAndAmortization	$497.0M	$491.0M	$465.0M	$448.0M	$441.0M
CashFlow - OperatingActivities - ShareBasedCompensation	$74.0M	$60.0M	$62.0M	$58.0M	$59.0M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-338.0M	$-61.0M	$-286.0M	$-80.0M	$-62.0M
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$133.0M	$536.0M	$242.0M	$583.0M	$652.0M
CashFlow - OperatingActivities - NetCashFromOperatingActivities(continuingOperations)	$3.0B	$2.4B	$1.9B	$2.2B	$2.1B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e&Intangibles)	$655.0M	$732.0M	$586.0M	$477.0M	$453.0M
CashFlow - InvestingActivities - ProceedsFromDivestitureOfBusinesses/assets	$293.0M	$96.0M	$0	$0	—
CashFlow - InvestingActivities - OtherInvestingActivities	$3.0M	$-2.0M	$0	$1.0M	$0
CashFlow - InvestingActivities - NetCashFromInvestingActivities(continuingOperations)	$-315.0M	$-777.0M	$-883.0M	$-458.0M	$-572.0M
CashFlow - FinancingActivities - RepaymentsOfDebt	$0	$1.4B	$0	$600.0M	$500.0M
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$1.9B	$1.1B	$1.6B	$743.0M	$250.0M
CashFlow - FinancingActivities - PaymentOfDividends	$786.0M	$692.0M	$611.0M	$474.0M	$380.0M
CashFlow - FinancingActivities - ProceedsFromStockOptionsExercised/SharePlans	$20.0M	$42.0M	$15.0M	$36.0M	$57.0M
CashFlow - FinancingActivities - NetCashFromFinancingActivities(continuingOperations)	$-2.7B	$-3.1B	$-904.0M	$-1.9B	$123.0M
CashFlow - CashReconciliationAndSupplemental - EffectOfExchangeRateChangesOnCash	$-32.0M	$-7.0M	$-29.0M	$-12.0M	$-7.0M
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$-54.0M	$-1.5B	$96.0M	$-119.0M	$1.7B
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$892.0M	$754.0M	$638.0M	$548.0M	$418.0M
CashFlow - CashReconciliationAndSupplemental - InterestPaid	$274.0M	$295.0M	$242.0M	$253.0M	$257.0M
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$46.0M	$73.0M	$99.0M	$39.0M	$47.0M

Zoetis

Balance Sheet 36 Accounts • 5 Years

Income Statement 22 Accounts • 5 Years

Cash Flow Statement 21 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History